Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.1400
+0.0200 (16.67%)
At close: Jul 7, 2026
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $12.24 million as of July 8, 2026. Its market cap has increased by 17.75% in one year.
Market Cap
12.24M
Enterprise Value
15.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 12.24M, a decrease of -89.63%. That is a compound annual growth rate of -7.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 12.24M | 198.51% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 16.86M |
| Zenith Capital | 15.97M |
| Brainstorm Cell Therapeutics | 15.89M |
| Anebulo Pharmaceuticals | 15.50M |
| Zeo ScientifiX | 14.89M |
| Galera Therapeutics | 14.68M |
| Inhibitor Therapeutics | 13.75M |
| LianBio | 12.44M |